Navigation Links
New NJIT book examines hemophilia and consequences of medical progress
Date:8/18/2011

ursuit entailed.

"I thought it was important to show readers the ironies as well as unintended consequences that are inherent to many of our ongoing efforts to manage disease," said Pemberton. "In the case of hemophilia, there was a collective effort to transform the patients' hopes for a normal life into a purchasable commodity. Ironically, this strategy made it all too easy for key actors and institutions in the United States to ignore the potential dangers of delivering greater health and autonomy to hemophilic boys and men. Thus, in seeking normalcy, our medical experts and their allies produced the opposite of normal; and it was among the most vulnerable groups in America who paid the ultimate price for this mistake."

Pemberton is in the Federated Department of History at NJIT and Rutgers University, Newark. He is coauthor of The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay-Sachs, Cystic Fibrosis, and Sickle Cell Disease, also published by Johns Hopkins.


'/>"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Book examines how trees change as they age and grow: What do these clues tell us?
2. Research examines how to apply conductive nanocoatings to textiles
3. Study examines folic acid absorption rates from softgel capsule and standard tablet
4. K-State doctoral graduate examines food bioterrorism for dissertation
5. New study examines immunity in emerging species of a major mosquito carrer of malaria
6. New book examines health and environmental impacts of common (and not-so-common) chemicals
7. Study examines risk of heterosexual HIV transmission in China
8. Physicist examines game theory on microbial level as part of UH Tenneco lecture series
9. What lies beneath: Study examines sediment movement during floods in rivers
10. Iowa State University researcher examines mosquito gene for new disease response
11. Research examines vicious cycle of overeating and obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New NJIT book examines hemophilia and consequences of medical progress
(Date:7/21/2015)... 2015 Today, ZTE announced its Android smartphone ... as expected revenues in 2015 that relate to sales of FPC1025 ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO ... manufacturer in China and we are proud ... 5 for Axon , its first ...
(Date:7/20/2015)... DENVER , July 20, 2015  Acuity ... Mobility Report: The Convergence of Commerce and Privacy" ... billion mobile biometric apps will be downloaded to ... users. The mobile biometrics market is projected to ... app revenue during the seven-year forecast period.    ...
(Date:7/9/2015)... Calif. , July 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... Thursday, July 30, 2015 after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... release is available in German . ... in Freiburg have gained important insights for stem cell research ... to the development of new treatments. As Rolf Kemler,s research ... determines the length of the telomeres and a signalling pathway ...
... , Akron, Ohio, June 27, 2012 Expertise in fluid ... a new research center designed to help physicians better diagnose ... neck and shoulders. Chiari malformation is a disorder of ... brain and spinal fluid. UA engineers are able to ...
... animal scientists are working together to meet the challenges of ... experimental Biology on 28th June will demonstrate innovative techniques and ... issues, crop yields and diminishing fish stocks. , In ... the world,s four most important crops has fallen short of ...
Cached Biology News:When does a headache need an engineer to fix it? 2When does a headache need an engineer to fix it? 3
(Date:7/23/2015)... ... 2015 , ... The health and wellness of brain tumor caregivers, often a ... tumor diagnosis. The American Brain Tumor Association presents interactive sessions that address shifting the ... July 24-25 in Chicago. , “We have understood for a long-time now that ...
(Date:7/23/2015)... , July 23, 2015 The Hong Kong ... given the prestigious accolade of "Most Innovative Technology ... world-class position in fostering innovation and technology development ... region.  The award has ... innovation and technology magazine and website with a ...
(Date:7/23/2015)... July 23, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") ... Biohaven Pharmaceutical Holding Company Limited (Biohaven), are pleased ... New Drug (IND) Application with the U.S. Food ... of BHV-0223. Portage holds 54% equity interest in ... a glutamate modulating agent and Biohaven has entered ...
(Date:7/23/2015)... July 23, 2015 /PRNewswire/ – Sigma-Aldrich Corporation (NASDAQ: ... technology company, today announced the Company has received ISO ... Dekalb and Barton ... . The certification extends Sigma-Aldrich,s ability to manufacture ... and antibodies used in diagnostic assays, and provides in ...
Breaking Biology Technology:Reframing the Caregiver and Patient Mindset: Coping with the ‘New Normal’ 2Reframing the Caregiver and Patient Mindset: Coping with the ‘New Normal’ 3HKSTP Wins Most Innovative Technology Hub at The New Economy Awards 2015 2HKSTP Wins Most Innovative Technology Hub at The New Economy Awards 2015 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 2Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 4Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials 2Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials 3
... 6 VIRxSYS Corporation announced today the publication ... Abundant Albumin Transcripts for Production of Therapeutic Proteins In ... The study describes a novel RNA therapy technique in which ... gene "hijacks" the albumin, causing it to produce the newly ...
... 6 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) ... has posted a new entry on his blog on ... recent meetings in Zurich, Switzerland, further development plans for ... for clinical-grade Oxycyte, and plans for raising additional capital. ...
... April 6 /PRNewswire/ - Orcrist Bio Inc. (ORC) ... today the approval of its Phase I, open-label, ... volunteers, by the European Competent Authority in Seville, ... assess the safety, tolerability, pharmacokinetics and pharmacodynamics (induction ...
Cached Biology Technology:VIRxSYS Publishes New Study on RNA Therapy 2Orcrist Bio Inc. Receives Approval from European Competent Authority to Initiate its Planned Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 2
... siTrio siRNA --- a cocktail of ... gene of interestis our most popular product. ... than 75% knockdown of your target gene ... siRNA for transfection and confirmation of optimal ...
... offers a large collection of phage ... tissuea, cell lines, and mouse tissues. ... pHD9 vector. The size of cDNA ... from 200bp to 1000bp by gel ...
... A multi-purpose, high gel-strength agarose suitable for ... from conventional constant field to Pulsed Field ... gel strength and exclusion limits, Multi ABgarose ... reduced running times. This in turn means ...
7G10 anti-Fasciclin III...
Biology Products: